Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for ArriVent BioPharma, Inc. Common Stock (AVBP).
- Disclosed ownership: 7.5%.
- Date of event: 11 Aug 2025.
ORBIMED ADVISORS LLC - 11 Aug 2025 SCHEDULE 13D/A Report for ArriVent BioPharma, Inc. Common Stock (AVBP)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- AVBP
- Shares outstanding
- 40,364,373 shares
- Disclosed Ownership
- 3,027,328 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13D/A
- Filing time
- 13 Aug 2025, 19:43:50 UTC
- Date of event
- 11 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 7.5% ownership in ArriVent BioPharma, Inc. Common Stock (AVBP) on 11 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 19:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.5% | 3,027,328 | 0 | 3,027,328 | /s/ Carl L. Gordon | Member | 0001055951 |
| OrbiMed Capital GP VIII LLC | 3.7% | 1,513,664 | 0 | 1,513,664 | /s/ Carl L. Gordon | Member of OrbiMed Advisors LLC | 0001845804 |
| OrbiMed Asia GP IV, L.P. | 3.7% | 1,513,664 | 0 | 1,513,664 | /s/ Carl L. Gordon | Director of OrbiMed Advisors IV Limited | 0001966836 |
| OrbiMed Advisors IV Limited | 3.7% | 1,513,664 | 1,513,664 | 0 | /s/ Carl L. Gordon | Director | 0001966835 |